#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14768	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2058	711.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	925	C	852	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27042	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3726	723.9	0	.	n	.	0	T695C	SNP	695	695	T	1101	1101	C	810	C	755	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27042	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3726	723.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1743	1743	A	888	A,G	815,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27042	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3726	723.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2377	2377	C	926	C,T,A	833,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27042	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3726	723.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3003	3003	T	821	T,C	768,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27042	23S	2890	2890	99.86	23S.l15.c30.ctg.1	3726	723.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2451	2451	A	905	A	846	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	V36A	NONSYN	106	108	GTG	485	487	GCG	205;206;207	G;C;G	185;188;189	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	527	529	CGG	189;186;185	C;G;G	175;173;174	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	S68L	NONSYN	202	204	TCG	581	583	TTG	161;159;160	T;T,C;G	153;153,1;153	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	A90V	NONSYN	268	270	GCG	647	649	GTT	183;179;180	G;T,C;T,G	170;161,2;165,2	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	I105V	NONSYN	313	315	ATT	692	694	GTT	148;147;147	G;T;T	140;137;140	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	N125T	NONSYN	373	375	AAT	752	754	ACC	148;148;147	A;C;C	139;137;140	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	R135C	NONSYN	403	405	CGT	782	784	TGT	158;162;162	T,C;G;T,C	139,1;146;144,2	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	K151E	NONSYN	451	453	AAA	830	832	GAA	137;138;142	GAAAA,GAAA;A;A	125,1;127;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	T152N	NONSYN	454	456	ACC	833	835	AAC	143;142;145	A;A,C;C	132;130,1;132	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	A172T	NONSYN	514	516	GCG	893	895	ACA	131;134;133	A;C;A	124;130;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	A175E	NONSYN	523	525	GCG	902	904	GAA	141;142;145	G;A;A	135;135;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	E176T	NONSYN	526	528	GAA	905	907	ACC	150;151;151	A;C;C	138;141;142	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	I178V	NONSYN	532	534	ATC	911	913	GTC	152;152;153	G;T;C	143;139;141	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	I188T	NONSYN	562	564	ATA	941	943	ACG	148;147;148	A;C;G	138;134;136	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	P200N	NONSYN	598	600	CCC	977	979	AAC	148;148;150	A;A;C	139;138;141	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1037	1039	TTG	147;146;147	T;T;G	139;138;140	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1094	1096	ACC	144;143;146	A;C;C	129;131;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1097	1099	GAC	148;148;148	G;A;C	138;138;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1106	1108	GCG	156;155;157	G;C;G	142;120;142	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1142	1144	GCT	157;159;160	G;C;T	140;142;136	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1598	folP	858	858	91.61	folP.l15.c4.ctg.1	1548	102.9	1	SNP	p	R230S	1	.	.	688	690	AGC	1067	1069	AGC	164;165;163	A;G;C	153;154;151	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4954	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3567	138.4	1	SNP	p	S91F	0	.	.	271	273	TCC	546	548	TCC	169;166;167	T;C;C	156;154;154	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4954	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3567	138.4	1	SNP	p	D95N	0	.	.	283	285	GAC	558	560	GAC	164;164;164	G;A;C	153;155;155	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4954	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3567	138.4	1	SNP	p	D95G	0	.	.	283	285	GAC	558	560	GAC	164;164;164	G;A;C	153;155;155	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1600	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1342	118.8	1	SNP	p	G45D	1	.	.	133	135	GAC	438	440	GAC	203;200;201	G;A;C	186;185;187	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	850	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1110	76.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2940	167.5	1	SNP	p	D86N	0	.	.	256	258	GAC	565	567	GAC	197;197;201	G;A;C	189;186;191	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2940	167.5	1	SNP	p	S87I	0	.	.	259	261	AGT	568	570	AGT	202;205;210	A;G;T	193;193;194	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2940	167.5	1	SNP	p	S87R	0	.	.	259	261	AGT	568	570	AGT	202;205;210	A;G;T	193;193;194	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2940	167.5	1	SNP	p	S87W	0	.	.	259	261	AGT	568	570	AGT	202;205;210	A;G;T	193;193;194	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4956	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2940	167.5	1	SNP	p	S88P	0	.	.	262	264	TCC	571	573	TCC	208;208;207	T;C;C	193;193;191	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4196	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2924	143.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1708	1710	GGC	193;191;190	G;G;C	182;179;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1263	1265	GCA	220;223;223	G,A;C;A	199,1;205;207	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1266	1268	ATC	224;221;225	A;T,C;C	210;207,1;209	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1278	1280	GTG	227;225;223	G;T;G	208;205;207	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1278	1280	GTG	227;225;223	G;T;G	208;205;207	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1782	1784	ACC	194;194;194	A;C;C	182;180;182	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1836	1838	GCG	178;183;186	G;C,G;G	152;139,1;148	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1836	1838	GCG	178;183;186	G;C,G;G	152;139,1;148	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1959	1961	GGC	158;159;160	G;G;C	144;145;146	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1968	1970	GGC	155;155;151	G,A;G;C	139,1;139;135	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3882	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2383	162.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1986	1988	CCG	125;129;132	C,G;C,T;G	92,2;95,1;96	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5682	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3106	182.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2310	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1793	128.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	570	570	C	167	C	155	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	G38E	NONSYN	112	114	GGA	506	508	GAA	217;215;210	G;A;A	196;197;194	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	S46G	NONSYN	136	138	AGC	530	532	GGC	203;201;202	G;G;C	188;187;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	E48G	NONSYN	142	144	GAA	536	538	GGA	206;207;208	G;G;A	191;191;193	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	T87A	NONSYN	259	261	ACT	653	655	GCT	223;226;227	G;C;T	203;205;205	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	T89S	NONSYN	265	267	ACC	659	661	AGC	229;228;231	A;G;C,T	213;210;212,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	.	MULTIPLE	358	359	AA	751	752	CG	222;222	C;G	203;199	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	.	MULTIPLE	361	362	GA	754	756	CAG	217;216;215	C;A;G	199;199;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	N122K	NONSYN	364	366	AAC	758	760	AAA	217;219;222	A;A;A	204;205;208	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	K143E	NONSYN	427	429	AAA	821	823	GAA	241;242;244	G;A;A	225;227;223	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	V151A	NONSYN	451	453	GTA	845	847	GCA	258;259;258	G;C;A	234;236;231	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1037	1039	ACT	200;195;192	A;C;T	190;187;184	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1046	1048	ATG	190;189;187	A;T;G	184;182;174	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1160	1162	GCA	234;236;234	G;C;A	218;219;219	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1163	1165	ACG	232;230;232	A;C;G	218;216;217	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1166	1168	GGG	232;236;233	G;G;G	216;219;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1169	1171	GTT	233;230;227	G;T;T	214;212;211	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1229	1231	GTA	219;216;212	G;T;A	197;193;192	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1268	1270	ACT	207;206;208	A;C;T	196;195;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1274	1276	GAT	215;212;209	G;A;T	201;198;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1286	1288	CAC	219;220;222	C;A;C	205;204;209	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	1	SNP	p	G120K	1	.	.	358	360	AAG	751	753	CGG	222;222;216	C;G;G	203;199;197	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	1	SNP	p	A121D	1	.	.	361	363	GAC	754	757	CGC	217;215;215	C;G;C	199;198;200	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2694	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1583	169.4	1	SNP	p	D121N	0	.	.	361	363	GAC	754	757	CGC	217;215;215	C;G;C	199;198;200	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10556	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	5002	210.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2137	2139	CAT	221;221;225	C;A;T	198;198;199	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1176	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	999	116.9	1	SNP	p	V57M	1	.	.	169	171	ATG	493	495	ATG	245;242;239	A,G;T;G	230,1;229;226	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
